Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats

American Journal of Physiology - Renal Physiology

Volumn 298, Issue 2, 2010, Pages

  Park, Jeong Woo ^a   Bae, Eun Hui ^a   Kim, In Jin ^a   Ma, Seong Kwon ^a   Choi, Chan ^a   Lee, Jongun ^a   Kim, Soo Wan ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Fibrosis; Inflammation

Indexed keywords

AQUAPORIN 1; COLLAGEN; GAMMA INTERFERON; GENTAMICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; PARICALCITOL; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; MACROPHAGE; MALE; MESENCHYME CELL; MONOCYTE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; TUBULAR DYSFUNCTION;

EID: 75149128639     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00471.2009     Document Type: Article

References (43)

1. Alexandridis G, Liberopoulos E, Elisaf M. Aminoglycoside-induced reversible tubular dysfunction. Pharmacology 67: 118-120, 2003.
2. Böttinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol 13: 2600-2610, 2002.
3. Brown AJ, Dusso A, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 277: F157-F175, 1999.
4. Brown SA, Sugimoto K, Smith GG, Garry FB. Improved sodium hydroxide digestion method without homogenization for extraction of gentamicin from renal tissue. Antimicrob Agents Chemother 32: 595-597, 1988.
5. Choi ME. Mechanism of transforming growth factor-beta1 signaling. Kidney Int Suppl 77: S53-S58, 2000.
6. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Di Paola R, Britti D, De Sarro A, Pierpaoli S, Caputi A, Masini E, Salvemini D. A role for superoxide in gentamicin-mediated nephropathy in rats. Eur J Pharmacol 450: 67-76, 2003.
7. Du M, Keeling KM, Fan L, Liu X, Bedwell DM. Poly-L- aspartic acid enhances and prolongs gentamicin-mediated suppression of the CFTR-G542X mutation in a cystic fibrosis mouse model. J Biol Chem 284: 6885-6892, 2009.
8. Feldman G, Kiely B, Martin N, Ryan G, McMorrow T, Ryan MP. Role for TGF-beta in cyclosporine-induced modulation of renal epithelial barrier function. J Am Soc Nephrol 18: 1662-1671, 2007.
9. Geleilete TJ, Melo GC, Costa RS, Volpini RA, Soares TJ, Coimbra TM. Role of myofibroblasts, macrophages, transforming growth factor-beta endothelin, angiotensin-II, and fibronectin in the progression of tubulointerstitial nephritis induced by gentamicin. J Nephrol 15: 633-642, 2002.
10. Guijarro C, Egido J. Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int 59: 415-424, 2001.
11. Ho AW, Wong CK, Lam CW. Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways. Immunobiology 213: 533-544, 2008.
12. Hocher B, Thöne-Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, Siegmund F, Quertermous T, Bauer C, Neumayer HH, Schleuning WD, Theuring F. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 99: 1380-1389, 1997.
13. Huwiler A, Pfeilschifter J. Transforming growth factor beta 2 stimulates acute and chronic activation of the mitogen-activated protein kinase cascade in rat renal mesangial cells. FEBS Lett 354: 255-258, 1994.
14. Inoki K, Haneda M, Ishida T, Mori H, Maeda S, Koya D, Sugimoto T, Kikkawa R. Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-beta in mesangial cells. Kidney Int Suppl 77: S76-S80, 2000.
15. Kuhlmann A, Haas CS, Gross ML, Reulbach U, Holzinger M, Schwarz U, Ritz E, Amann K. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol 286: F526-F533, 2004.
16. Li Y, Spataro BC, Yang J, Dai C, Liu Y. 1,25-Dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression. Kidney Int 68: 1500-1510, 2005.
17. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15: 1-12, 2004.
18. T) method. Methods 25: 402-408, 2001.
19. Lo WK. Serum parameters, inflammation, renal function and patient outcome. Contrib Nephrol 150: 152-155, 2006.
20. Mackensen-Haen S, Bader R, Grund KE, Bohle A. Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate. Clin Nephrol 15: 167-171, 1981.
21. Makibayashi K, Tatematsu M, Hirata M, Fukushima N, Kusano K, Ohashi S, Abe H, Kuze K, Fukatsu A, Kita T, Doi T. A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. Am J Pathol 158: 1733-1741, 2001.
22. Masaki T, Foti R, Hill PA, Ikezumi Y, Atkins RC, Nikolic-Paterson DJ. Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int 63: 1256-1264, 2003.
23. Miyajima A, Kosaka T, Seta K, Asano T, Umezawa K, Hayakawa M. Novel nuclear factor kappa B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction. J Urol 169: 1559-1563, 2003.
24. Mizobuchi M, Morrissey J, Finch JL, Martin DR, Liapis H, Akizawa T, Slatopolsky E. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats. J Am Soc Nephrol 18: 1796-1806, 2007.
25. Moestrup SK, Cui S, Vorum H, Bregengård C, Bjørn SE, Norris K, Gliemann J, Christensen EI. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J Clin Invest 96: 1404-1413, 1995.
26. Nagai J, Tanaka H, Nakanishi N, Murakami T, Takano M. Role of megalin in renal handling of aminoglycosides. Am J Physiol Renal Physiol 281: F337-F344, 2001.
27. Olesen ET, de Seigneux S, Wang G, Lütken SC, Frøkiaer J, Kwon TH, Nielsen S. Rapid and segmental specific dysregulation of AQP2, S256-pAQP2 and renal sodium transporters in rats with LPS-induced endotoxaemia. Nephrol Dial Transplant 24: 2338-2349, 2009.
28. 3 in experimental mesangial proliferative nephritis in rats. Kidney Int 60: 87-95, 2001.
29. Parlakpinar H, Ozer MK, Sahna E, Vardi N, Cigremis Y, Acet A. Amikacin-induced acute renal injury in rats: protective role of melatonin. J Pineal Res 35: 85-90, 2003.
30. Rosenau C, Emery D, Kaboord B, Qoronfleh MW. Development of a high-throughput plate-based chemiluminescent transcription factor assay. J Biomol Screen 9: 334-342, 2004.
31. Schlondorff DO. Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney Int 74: 860-866, 2008.
32. Schmidt C, Höcherl K, Schweda F, Kurtz A, Bucher M. Regulation of renal sodium transporters during severe inflammation. J Am Soc Nephrol 18: 1072-1083, 2007.
33. Segerer S, Nelson PJ, Schlöndorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11: 152-176, 2000.
34. Tan X, Li Y, Liu Y. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 17: 3382-3393, 2006.
35. Tan X, Li Y, Liu Y. Therapeutic role and potential mechanisms of active vitamin D in renal interstitial fibrosis. J Steroid Biochem Mol Biol 103: 491-496, 2007.
36. Tan X, Wen X, Liu Y. Paricalcitol inhibits renal inflammation by promoting vitamin d receptor-mediated sequestration of NF-kappaB signaling. J Am Soc Nephrol 19: 1741-1752, 2008.
37. Tang WW, Feng L, Mathison JC, Wilson CB. Cytokine expression, upregulation of intercellular adhesion molecule-1, and leukocyte infiltration in experimental tubulointerstitial nephritis. Lab Invest 70: 631-638, 1994.
38. Trotter KW, Archer TK. Reconstitution of glucocorticoid receptor-dependent transcription in vivo. Mol Cell Biol 24: 3347-3358, 2004.
39. Volpini RA, Costa RS, da Silva CG, Coimbra TM. Inhibition of nuclear factor-kappaB activation attenuates tubulointerstitial nephritis induced by gentamicin. Nephron Physiol 98: 97-106, 2004.
40. Weinreich T, Merke J, Schönermark M, Reichel H, Diebold M, Hänsch GM, Ritz E. Actions of 1,25-dihydroxyvitamin D3 on human mesangial cells. Am J Kidney Dis 18: 359-366, 1991.
41. Weinreich T, Müller A, Wüthrich RP, Booy C, Binswanger U. 1,25-dihydroxyvitamin D3 and the synthetic vitamin D analogue, KH 1060, modulate the growth of mouse proximal tubular cells. Kidney Blood Press Res 19: 325-331, 1996.
42. 3 and glucocorticoid pathways. Biochem Biophys Res Commun 297: 645-652, 2002.
43. Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, Kneitz S, Piek E, Bottinger EP. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci USA 98: 6686-6691, 2001.